window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 29, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Advanced Therapies

  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Tonix Pharmaceuticals in-licenses TNX-4800, a long-acting monoclonal antibody for Lyme disease prevention

    Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) has acquired worldwide rights [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Formation Bio expands leadership team with biotech and pharma veterans to accelerate AI-driven drug development

    Formation Bio, the AI-native pharmaceutical company advancing a new model [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Kairos Pharma reports positive interim results from phase 2 trial of ENV105 in advanced prostate cancer

    Kairos Pharma has announced encouraging interim efficacy results from its [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Chrysalis appoints Adam Bartley as chief operating officer

    Chrysalis, a provider of GMP cleanroom hosting and support services [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Medical devices,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    Terumo BCT expands access to rare disease therapies across Latin America

    Terumo Blood and Cell Technologies has announced regulatory approvals for [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    Saphnelo self-administration Phase 3 trial meets primary endpoint in systemic lupus erythematosus

    AstraZeneca has reported positive interim results from the Phase 3 [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas

    KBI Biopharma and Infinimmune partner on antibody manufacturing for atopic dermatitis programme

    KBI Biopharma has entered a collaboration with Infinimmune to support [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Opinion & Events,Therapeutic Areas

    Cook MyoSite and Veristat progress Phase 3 trial of cell therapy for women with chronic incontinence

    Cook MyoSite and Veristat have reached a key enrolment milestone [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics

    CellProthera publishes Phase 1/2b results of stem cell therapy for post-heart attack patients

    CellProthera has published peer-reviewed results from its phase 1/2b Excellent [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Symeres acquires DGr Pharma to enhance regulatory expertise and expand biopharma capabilities

    Symeres, a global contract research, development and manufacturing organization, has [...]

    May 5, 2026
Previous151617Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Grifols launches Fesilty in US for congenital fibrinogen deficiency
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • NICE recommends pirtobrutinib for relapsed chronic lymphocytic leukaemia
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Cellares secures $50M investment to expand automated cell therapy manufacturing
    Categories: Advanced Therapies, Biotech & Pharma Business, Manufacturing & Supply Chain
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top